3SBio says Liping Xu is retiring for health reasons; Peiguo Cong will be new ...
News | 10 March 2010
NEW YORK (AP) - Chinese biotechnology company 3SBio Inc. said Wednesday that Liping Xu, one of the company's founders, is retiring from its board of ...
Click on the link to read the full article at CanadianBusiness.com
(This link will open in a new window)
- Ono Pharma buys Japanese rights to two cancer drugs in $340 million deal with Onyx
- GlaxoSmithKline sells Croatian research center to Galapagos, names new CFO and enters supply deal with Lonza; EMEA update on Avandia and Pandemrix
- Wyeth/Pfizer accused of using ghostwritten articles to overstate benefits of HRT
- China’s liver cancer drug market forecast to nearly triple to $144 million in 2014
- International sales rep quality survey views BRIC markets
